Leite John 4

What Happened

• John Leite, Chief Commercial Officer (CLIA) of Veracyte, was granted two restricted stock unit (RSU) awards on March 6, 2026: 36,181 RSUs and 6,578 RSUs, a total of 42,759 RSUs. Each grant is reported as acquired at $0.00 (award/grant, transaction code A).

Key Details

• Transaction date: March 6, 2026; filing date: March 10, 2026 (Form 4 filed within the standard two-business-day window).
• Reported acquisition: 36,181 RSUs (A, $0.00) and 6,578 RSUs (A, $0.00); total 42,759 RSUs.
• Shares owned after transaction: not disclosed in the provided filing details.
• Footnotes in the filing:
  • F1: The 36,181 RSUs vest 25% on March 2, 2027 and then 1/16 per quarter thereafter, subject to continued employment.
  • F2: The 6,578 RSUs vest in full on the first anniversary of the grant, subject to continued employment.
• No 10b5-1 plan, tax-withholding election, or sale/transfer noted in the reported transactions.

Context

• These are compensation awards (RSUs), not open-market purchases or sales. RSUs convert to shares only as they vest, so they do not represent an immediate buy or sell signal. Vesting schedules and continued employment conditions determine when Leite will actually receive shares.